autologous tetravalent dendritic cell vaccine MIDRIX4-LUNG

{
  "id": "MLC-T-ONC-011773",
  "term": "autologous tetravalent dendritic cell vaccine MIDRIX4-LUNG",
  "field": "Oncology and biomedicine",
  "definition": "A therapeutic cancer vaccine composed of autologous, dendritic cells (DCs) that have been loaded with a proprietary selection of four antigens that covers more than ninety percent of all non-small cell lung cancer (NSCLC) patients, with potential immunostimulatory and antineoplastic activities. Upon administration, autologous tetravalent dendritic cell vaccine MIDRIX4-LUNG may induce and stimulate both T-helper and antigen-specific cytotoxic T-lymphocyte (CTL) responses, leading to tumor cell lysis in patients with NSCLC.",
  "synonyms": [
    "autologous tetravalent DC vaccine MIDRIX4-LUNG",
    "autologous DC vaccine MIDRIX4-LUNG",
    "tetravalent autologous dendritic cell vaccine MIDRIX4-LUNG"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/autologous-tetravalent-dendritic-cell-vaccine-midrix4-lung/"
}